These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 18412986

  • 1. The vitamin D receptor in cancer.
    Thorne J, Campbell MJ.
    Proc Nutr Soc; 2008 May; 67(2):115-27. PubMed ID: 18412986
    [Abstract] [Full Text] [Related]

  • 2. Targets of vitamin D receptor signaling in the mammary gland.
    Welsh J.
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D and prevention of breast cancer.
    Welsh J.
    Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
    [Abstract] [Full Text] [Related]

  • 4. Epigenetic corruption of VDR signalling in malignancy.
    Abedin SA, Banwell CM, Colston KW, Carlberg C, Campbell MJ.
    Anticancer Res; 2006 Sep; 26(4A):2557-66. PubMed ID: 16886664
    [Abstract] [Full Text] [Related]

  • 5. The vitamin D receptor as a therapeutic target.
    Campbell MJ, Adorini L.
    Expert Opin Ther Targets; 2006 Oct; 10(5):735-48. PubMed ID: 16981830
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
    Choi M, Makishima M.
    Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
    [Abstract] [Full Text] [Related]

  • 7. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
    Valrance ME, Welsh J.
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D resistance.
    Bouillon R, Verstuyf A, Mathieu C, Van Cromphaut S, Masuyama R, Dehaes P, Carmeliet G.
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):627-45. PubMed ID: 17161336
    [Abstract] [Full Text] [Related]

  • 9. Increased apoptosis of periprostatic adipose tissue in VDR null mice.
    Guzey M, Jukic D, Arlotti J, Acquafondata M, Dhir R, Getzenberg RH.
    J Cell Biochem; 2004 Sep 01; 93(1):133-41. PubMed ID: 15352170
    [Abstract] [Full Text] [Related]

  • 10. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
    Yin Y, Ni J, Chen M, Guo Y, Yeh S.
    Clin Cancer Res; 2009 Jan 01; 15(1):190-200. PubMed ID: 19118046
    [Abstract] [Full Text] [Related]

  • 11. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
    Hourai S, Rodrigues LC, Antony P, Reina-San-Martin B, Ciesielski F, Magnier BC, Schoonjans K, Mouriño A, Rochel N, Moras D.
    Chem Biol; 2008 Apr 01; 15(4):383-92. PubMed ID: 18420145
    [Abstract] [Full Text] [Related]

  • 12. The classic receptor for 1alpha,25-dihydroxy vitamin D3 is required for non-genomic actions of 1alpha,25-dihydroxy vitamin D3 in osteosarcoma cells.
    Bravo S, Paredes R, Izaurieta P, Lian JB, Stein JL, Stein GS, Hinrichs MV, Olate J, Aguayo LG, Montecino M.
    J Cell Biochem; 2006 Nov 01; 99(4):995-1000. PubMed ID: 16927375
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
    Xu H, McCann M, Zhang Z, Posner GH, Bingham V, El-Tanani M, Campbell FC.
    Mol Carcinog; 2009 Aug 01; 48(8):758-72. PubMed ID: 19184984
    [Abstract] [Full Text] [Related]

  • 14. [VDR knockout mice and bone mineralization disorders].
    Takeyama K, Yamamoto Y, Kato S.
    Clin Calcium; 2007 Oct 01; 17(10):1560-6. PubMed ID: 17906409
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention.
    Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh JC, Slater S, Jurutka PW.
    Nutr Rev; 2008 Oct 01; 66(10 Suppl 2):S98-112. PubMed ID: 18844852
    [Abstract] [Full Text] [Related]

  • 16. The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences.
    Bandera Merchan B, Morcillo S, Martin-Nuñez G, Tinahones FJ, Macías-González M.
    J Steroid Biochem Mol Biol; 2017 Mar 01; 167():203-218. PubMed ID: 27913313
    [Abstract] [Full Text] [Related]

  • 17. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo.
    Matsubara T, Yoshinari K, Aoyama K, Sugawara M, Sekiya Y, Nagata K, Yamazoe Y.
    Drug Metab Dispos; 2008 Oct 01; 36(10):2058-63. PubMed ID: 18645036
    [Abstract] [Full Text] [Related]

  • 18. Intervention in autoimmunity: the potential of vitamin D receptor agonists.
    Adorini L.
    Cell Immunol; 2005 Feb 01; 233(2):115-24. PubMed ID: 15936743
    [Abstract] [Full Text] [Related]

  • 19. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P, Dunlop T, Seifert M, Tilgen W, Reichrath J.
    Anticancer Res; 2009 Sep 01; 29(9):3647-58. PubMed ID: 19667161
    [Abstract] [Full Text] [Related]

  • 20. UV radiation and cancer prevention: what is the evidence?
    Krause R, Matulla-Nolte B, Essers M, Brown A, Hopfenmüller W.
    Anticancer Res; 2006 Sep 01; 26(4A):2723-7. PubMed ID: 16886683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.